SCHEMBL189530

SCHEMBL189530

Cc1noc(C)c1CCl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6299008 0.98 LMNA (0.48)
SCHEMBL2238495 0.83 LMNA (0.48)
SCHEMBL30643951 0.81
SCHEMBL11860376 0.80 LMNA (0.47)
SCHEMBL2056168 0.77
SCHEMBL96071 0.75
SCHEMBL5808175 0.75
SCHEMBL5808177 0.75
SCHEMBL314480 0.75
SCHEMBL3906075 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 875 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117003705-A Novel 1,2, 3-triazole compound with anti-tumor effect, and preparation method and application thereof 北京中医药大学 2023-11-07 CN claimed
CN-116284046-A Ballon Sha Wei derivative, and preparation method and application thereof 山东新华制药股份有限公司 2023-06-23 CN claimed
CN-112979571-A AKR1C3 selective inhibitor, preparation method and application thereof 中国药科大学 2021-06-18 CN claimed
US-20180273906-A1 MICROVESICLE AND STEM CELL COMPOSITIONS FOR THERAPEUTIC APPLICATIONS IPS HEART 2018-09-27 US claimed
US-5939568-A Accelerated catalysis of olefinic epoxidations THE SCRIPPS RESEARCH INSTITUTE (US) 1999-08-17 US claimed
CN-122059992-A AKR1C3 selectively activated small molecule drug conjugate and application thereof 中国药科大学 2026-05-19 CN disclosed
CN-122036638-A AKR1C3 inhibitor with tricyclic structure and application thereof 中国药科大学 2026-05-15 CN disclosed
US-12486258-B2 Compounds and methods for regulating insulin secretion THE BROAD INSTITUTE, INC. (US) 2025-12-02 US disclosed
CN-119591637-A Compound with aryl amide structure and medical application thereof 南京芩领医药科技有限公司 2025-03-11 CN disclosed
CN-118994135-A Compound with aryl amide structure and medical application thereof 南京芩领医药科技有限公司 2024-11-22 CN disclosed
CN-118994241-A Compound with aryl amide structure and application thereof 南京芩领医药科技有限公司 2024-11-22 CN disclosed
US-20240368133-A1 Compounds for the Treatment of Pain, in Particular, Neuropathic Pain, and/or Other Diseases or Disorders that are Associated with AT2R and/or AT2R Mediated Signaling CONFO THERAPEUTICS N.V. (BE) 2024-11-07 US disclosed
US-4024271-A INHIBITORS OF HISTAMINE ACTIVITY SMITH KLINE & FRENCH LABORATORIES LIMITED (EN) 1977-05-17 US disclosed
US-4022797-A PHARMACEUTICALS SMITH KLINE & FRENCH LABORATORIES LIMITED (EN) 1977-05-10 US disclosed
US-4018931-A INHIBITION OF H-2 HISTAMINE RECEPTORS SMITH KLINE & FRENCH LABORATORIES LIMITED (EN) 1977-04-19 US disclosed
US-3985771-A Total steroid synthesis employing substituted isoxazole derivatives HOFFMANN-LA ROCHE INC. (US) 1976-10-12 US disclosed
US-3984428-A Isoxazolyl-substituted perhydrobenzindenes HOFFMANN-LA ROCHE INC. (US) 1976-10-05 US disclosed
US-3984427-A Preparation of vinyl lactones and corresponding Mannich bases HOFFMANN-LA ROCHE INC. (US) 1976-10-05 US disclosed
US-3950333-A HISTAMINE INHIBITORS, OXYALKYL, THIOALKYL, AMINOALKYL DERIVATIVES SMITH KLINE & FRENCH LABORATORIES LIMITED (EN) 1976-04-13 US disclosed
US-3950353-A HISTAMINE INHIBITORS SMITH KLINE & FRENCH LABORATORIES LIMITED (EN) 1976-04-13 US disclosed